ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration
Published: 03/07/17, 10:41am (AEST)•3 pages